In vitro effect of cefoxitin on phagocytic function and antibody-dependent cellular cytotoxicity in human neutrophils (Unbekannt)
- Neue Suche nach: Rodriguez, A. B.
- Neue Suche nach: Barriga, C.
- Neue Suche nach: De la Fuente, M.
- Neue Suche nach: Rodriguez, A. B.
- Neue Suche nach: Barriga, C.
- Neue Suche nach: De la Fuente, M.
In:
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
;
16
, 1
;
39
;
1993
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:In vitro effect of cefoxitin on phagocytic function and antibody-dependent cellular cytotoxicity in human neutrophils
-
Beteiligte:
-
Erschienen in:
-
Verlag:
- Neue Suche nach: PERGAMON PRESS
-
Erscheinungsdatum:01.01.1993
-
Format / Umfang:39 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Unbekannt
- Neue Suche nach: 616 / 578
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 16, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Principles of paramunization. Option and limits in veterinary medicineBüttner, M. et al. | 1992
- 11
-
The modern epidemiological aspects of rabies in the worldChomel, Bruno B. et al. | 1992
- 21
-
Electron- and immunoelectron-microscopic investigation on the rabbit haemorrhagic disease virusAlexandrov, M. / Peshev, R. / Bozhkov, S. / Yanchev, I. / Doumanova, L. et al. | 1992
- 29
-
Effect of physical exercise on the phagocytic function of peritoneal macrophages from Swiss miceDe la Fuente, M. / Martín, I. / Ortega, E. et al. | 1992
- 39
-
In vitro effect of cefoxitin on phagocytic function and antibody-dependent cellular cytotoxicity in human neutrophilsRodriguez, A.B. / Barriga, C. / De la Fuente, M. et al. | 1992
- 51
-
Incidence of Aeromonas species in diarrhoeic stool in University College Hospital Ibadan, NigeriaAshiru, J.O. / Salau, T. / Rotilu, I.O. et al. | 1992
- 55
-
Effect of polyions on the infectivity of SA-11 rotavirus in LCC-MK2 cellsSuperti, Fabiana / Marziano, Maria Luisa / Tinari, Antonella / Donelli, Gianfranco et al. | 1992
- 63
-
Protection against bovine leukemia virus infection in two breeds of cattleKukaine, R.A. / Nagayeva, L.I / Chapenko, S.V. / Iljinskaya, T.N. / Bratsslavskaya, O.I. / Vitolin, L.A. / Yanchev, I.K. / Bozhkov, S. / Alexandrov, I.I. / Stefanova, R.N. et al. | 1992
- 73
-
The development of Pneumocystis carinii pneumonia in germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii organismWolff, L. / Horch, S. / Gemsa, D. et al. | 1992
- 77
-
Characterization of Pasteurella from gingival scrapings of dogs and catsGaniere, Jean Pierre / Escande, Françoise / Andre, Geneviève / Larrat, Myriam et al. | 1992
- 87
-
The isolation of cytotoxic necrotizing factor (CNF)-producing Escherichia coli from the intestinal contents of babies who died of Sudden Infant Death Syndrome (SIDS) and other causes as well as from the faeces of healthy babiesBettelheim, K.A. / Evangelidis, H. / Pearce, J.L. / Goldwater, P.N. / Luke, R.K.J. et al. | 1992
- 91
-
Detection of tumor necrosis factor activity in the supernatants of feline macrophages and lymphocytesLin, Dah-Sheng / Bowman, Dwight D. et al. | 1992
- i
-
33850 Test kit and method for the determination of streptococcus a antigen| 1993
- i
-
5091364 Preparation of immunologically active cell wall components from archaebacteria| 1993
- i
-
5091327 Fabrication of a high density stacked gate EPROM split cell with bit line reach-through and interruption immunity| 1993
- IFC
-
Editorial Board| 1993
- ii
-
5091368 Biologically active compounds from blue-green algae| 1993
- ii
-
5093114 Treatment of human viral infections| 1993
- ii
-
5093230 Method for rapid and sensitive detection of IgM retroviral antibodies| 1993
- ii
-
5091389 Lipophilic macrolide useful as an immunosuppressant| 1993
- ii
-
5093258 Recombinant fowlpox virus and recombination vector| 1993
- ii
-
5091511 Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it| 1993
- iii
-
5094850 Process for the preparation of inducers of non-specific immunity and product produced| 1993
- iii
-
5095093 Protective four amino acid epitope against Plasmodium vivax malaria| 1993
- iii
-
5093318 Immunostimulating guanosine derivatives and their pharmaceutical compositions| 1993
- iii
-
5093320 Novel peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same| 1993
- iii
-
5093338 Lipophilic macrolide useful as an immunosuppressant| 1993
- iv
-
5095095 Immunosuppressant factor protein capable of inhibiting C-cell mechanisms| 1993
- iv
-
5096922 Macrocyclic antibodies| 1993
- iv
-
5096810 Monoclonal antibodies for diagnosis of hairy cell leukemia| 1993
- iv
-
5096704 Method of treating eosinophilia| 1993
- iv
-
5098708 Antiviral antibiotic BU-3889V| 1993
- ix
-
5120717 Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodeficiency syndrome| 1993
- ix
-
5120525 Radiolabeled antibody cytotoxic therapy of cancer| 1993
- ix
-
5120642 Monoclonal antibody which distinguishes helper inducer and suppressor inducer CD4+ lymphocytes| 1993
- ix
-
5120640 Placental isoferritins for the prognosis and diagnosis of immunosuppression| 1993
- v
-
5098998 Cholera vaccines and peptides| 1993
- v
-
5100776 Immunological detection process for herbicides| 1993
- v
-
5098827 Novel bacterial markers for pathogenic group B streptococci| 1993
- v
-
5100664 Human IL-2 as a vaccine adjuvant| 1993
- v
-
5099005 Method of enhancing immunoglobulin fragment production| 1993
- vi
-
5103767 Method and a machine for the vaccination of fish| 1993
- vi
-
5104620 Disposable allergy skin testing kit| 1993
- vi
-
5100777 Antibody matrix device and method for evaluating immune status| 1993
- vi
-
5103836 Oral collection device and kit for immunoassay| 1993
- vi
-
5104650 Uses of recombinant colony stimulating factor-1| 1993
- vii
-
5118501 Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies| 1993
- vii
-
5118602 Feline t-lymphotropic lentivirus assay| 1993
- vii
-
5118610 Techniques for detecting insect contamination of foodstuffs| 1993
- vii
-
5118502 Naturally attenuated newcastle disease vaccine and method of using the same| 1993
- vii
-
5118606 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products| 1993
- viii
-
5118791 Biologically active polypeptides based on transforming growth factor- beta sequences and methods of use| 1993
- viii
-
5118618 Dimethylglycine enhancement of antibody production| 1993
- viii
-
5118669 Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators| 1993
- viii
-
5118789 Antibacterial polypeptides from sacrophaga peregrina| 1993
- viii
-
5120504 Apparatus for immunoassays with vent chennels in the container side wall| 1993
- x
-
5108745 Tuberculosis and legionellosis vaccines and methods for their production| 1993
- x
-
5108934 Quantitative immunoassay utilizing liposomes| 1993
- x
-
5109016 Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions| 1993
- x
-
5108744 Vaccines for haemophilus influenzae| 1993
- xi
-
5110589 Swine dysentery subunit vaccine and method| 1993
- xi
-
5110587 Immunogenic composition comprising synthetically modified vaccinia virus| 1993
- xi
-
5109026 2-Component immunoadjuvant| 1993
- xi
-
5110588 Composite salmonella E. coli, vibrio cholerae vaccine strains| 1993
- xi
-
5110908 Haemophilus influenzae peptides and proteins| 1993
- xii
-
5112756 Continuous production of bovine Maedi-Visna-Like viral antigens in CF2TH cells| 1993
- xii
-
5112735 Detection of lymphocyte amplification| 1993
- xii
-
5112749 Vaccines for the malaria circumsporozoite protein| 1993
- xii
-
5110910 Virucidal euglobulin precipitation| 1993
- xiii
-
5112954 Method of enhancing the effect of cytotoxic agents| 1993
- xiii
-
5112952 Composition and method for isolation and purification of immunoglobulin M| 1993
- xiii
-
5112948 Methods and compositions for inducing monocyte cytotoxicity| 1993
- xiii
-
5114708 Method for stimulating growth in animals| 1993
- xiv
-
5114973 Method for treating autoimmune disease using succinylacetone| 1993
- xiv
-
5116766 Immune complex isolation| 1993
- xiv
-
5115097 Synthetic peptide from the carboxy terminal of human MN-superoxide dismutase| 1993
- xiv
-
5116612 Immunotherapy agents for treatment of ige mediated allergies| 1993
- xv
-
5116946 Synthetic, immunologically active peptides useful for the preparation of antimalarial vaccines| 1993
- xv
-
5122372 Process for treatment of allergies| 1993
- xv
-
5122449 Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens| 1993
- xv
-
5122447 Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen| 1993
- xv
-
5122446 Method for detecting antibodies to human immunodeficiency virus| 1993
- xvi
-
5124147 Method for the treatment of endotoxic shock in a mammal| 1993
- xvi
-
5122453 Method for discriminating surface stained lymphocytes| 1993
- xvi
-
5122468 Hut-78 cell lines infected with HTLV-III which secrete GP160| 1993
- xvi
-
5124153 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products| 1993
- xvi
-
5124148 Method for treating viral diseases with attenuated virus| 1993
- xvii
-
5124267 Method for the determination of small substance quantities of medicines, of endogenous or other chemical compounds in biological material| 1993
- xvii
-
5126132 Tumor infiltrating lymphocytes as a treatment modality for human cancer| 1993
- xvii
-
5126131 Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates| 1993
- xvii
-
5128128 Virus vaccine| 1993
- xvii
-
5128129 Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same| 1993
- xviii
-
5128270 Assay of monokines| 1993
- xviii
-
5128259 Factor-dependent hematopoietic cell line exhibiting epo-induced erythrocyte maturation| 1993